On July 31, we discussed Moderna, one of the two big C-19 vaccine manufacturers. We discussed two situations: earnings and the longer-term trend. This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Tags:#mRNA Share: Mark W. Guthner, CFA Previous Post Microstrategy Update: MSTRNext PostNVIDIA: NVDA You Might Also Like Home Depot: HD April 13, 2022 Ark Innovation Fund: ARKK August 7, 2024 Salesforce: CRM April 8, 2024
You Might Also Like Home Depot: HD April 13, 2022 Ark Innovation Fund: ARKK August 7, 2024 Salesforce: CRM April 8, 2024
